Home › Atherosclerosis › Illinois › Chicago
Atherosclerosis clinical trials in Chicago, IL
4 studies for Atherosclerosis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Great Lakes Clinical Trials - Ravenswood, Chicago
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Eagle Clinical Research, Chicago
- University of Chicago, Chicago
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Chicago
- Research Site, Chicago
- Research Site, Chicago
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Chicago Clinical Research Inst, Chicago
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Hialeah, FL8 studies
- Miami, FL7 studies
- Durham, NC7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Memphis, TN7 studies
- Omaha, NE6 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)52 studies
- Prostate Cancer45 studies
- Metastatic Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer37 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight27 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.